
ADAR1 CAPITAL MANAGEMENT, LLC
Latest 13F filing data - Q4 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | IKT | 8.06M | $16.53M |
![]() | EQ | 5.61M | $8.69M |
![]() | ABUS | 5.42M | $26.05M |
![]() | OVID | 4.29M | $6.98M |
![]() | CTMX | 4.18M | $17.82M |
![]() | IVVD | 3.90M | $9.63M |
![]() | ROIV | 3.43M | $74.41M |
![]() | IVA | 2.71M | $12.60M |
![]() | TSHA | 2.50M | $13.73M |
![]() | IMVT | 2.48M | $63.07M |
![]() | PALI | 2.00M | $4.71M |
![]() | PCSC | 1.96M | $25.50M |
![]() | ELDN | 1.82M | $2.75M |
![]() | TNYA | 1.51M | $1.07M |
![]() | INO | 1.49M | $2.58M |
![]() | PRTA | 1.46M | $13.92M |
![]() | SVRA | 1.41M | $8.47M |
![]() | LXEO | 1.39M | $13.83M |
![]() | ABVX | 1.32M | $177.65M |
![]() | FULC | 1.25M | $14.18M |

Inhibikase Therapeutics, Inc.
IKT
Shares Held
8.06M
Value
$16.53M

Equillium, Inc.
EQ
Shares Held
5.61M
Value
$8.69M

Arbutus Biopharma Corporation
ABUS
Shares Held
5.42M
Value
$26.05M

Ovid Therapeutics Inc.
OVID
Shares Held
4.29M
Value
$6.98M

CytomX Therapeutics, Inc.
CTMX
Shares Held
4.18M
Value
$17.82M

Invivyd, Inc.
IVVD
Shares Held
3.90M
Value
$9.63M

Roivant Sciences Ltd.
ROIV
Shares Held
3.43M
Value
$74.41M

Inventiva S.A.
IVA
Shares Held
2.71M
Value
$12.60M

Taysha Gene Therapies, Inc.
TSHA
Shares Held
2.50M
Value
$13.73M

Immunovant, Inc.
IMVT
Shares Held
2.48M
Value
$63.07M

Palisade Bio, Inc.
PALI
Shares Held
2.00M
Value
$4.71M

Perceptive Capital Solutions Corp Class A Ordinary Shares
PCSC
Shares Held
1.96M
Value
$25.50M

Eledon Pharmaceuticals, Inc.
ELDN
Shares Held
1.82M
Value
$2.75M

Tenaya Therapeutics, Inc.
TNYA
Shares Held
1.51M
Value
$1.07M

Inovio Pharmaceuticals, Inc.
INO
Shares Held
1.49M
Value
$2.58M

Prothena Corporation plc
PRTA
Shares Held
1.46M
Value
$13.92M

Savara Inc.
SVRA
Shares Held
1.41M
Value
$8.47M

Lexeo Therapeutics, Inc. Common Stock
LXEO
Shares Held
1.39M
Value
$13.83M

Abivax S.A.
ABVX
Shares Held
1.32M
Value
$177.65M

Fulcrum Therapeutics, Inc.
FULC
Shares Held
1.25M
Value
$14.18M
